Brief: Commodore Capital LP Reports 9.99% Passive Stake In Inhibikase Therapeutics Inc As Of Oct 9, 2024- SEC Filing
17/10/2024 21:12
Oct 17 (Reuters) - Inhibikase Therapeutics Inc IKT.O :
* COMMODORE CAPITAL LP REPORTS 9.99% PASSIVE STAKE IN
INHIBIKASE
THERAPEUTICS INC AS OF OCT 9, 2024- SEC FILING
Source text for Eikon: ID:n0001493152-24-041408
Further company coverage: IKT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Inhibikase Therapeutics
See all newsBrief: Inhibikase Therapeutics Prices Public Offering Of 46 Million Shares At $1.45 Per Share
Brief: Inhibikase Therapeutics Announces Proposed Public Offering Of Common Stock And Pre-Funded Warrants
Brief: Inhibikase Therapeutics Advancing IKT-001 To Global Phase 3 Study In Pulmonary Arterial Hypertension
Cardiopulmonary drugmaker Inhibikase Therapeutics' Q3 net loss widens
Inhibikase Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary